AZTA
NASDAQ
US
Azenta, Inc. - Common Stock
$22.63
▲ +$1.45
(+6.85%)
Vol 1.1M
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.5B
ROE
-3.3%
Margin
-9.4%
D/E
0.09
Beta
1.35
52W
$24–$56
Wall Street Consensus
14 analysts · Apr 20263
Strong Buy
6
Buy
5
Hold
0
Sell
0
Strong Sell
64.3%
Buy Rating
Price Chart
Similar Stocks
SHC
Sotera Health Co
P/E 90.4
$5.0B
TXG
10X Genomics Inc
$2.1B
ADPT
Adaptive Biotechnologies Corp
$2.5B
BLFS
BioLife Solutions Inc
$1.2B
FTRE
Fortrea Holdings Inc
$1.6B
PSNL
Personalis Inc
$706.9M
CTKB
Cytek Biosciences Inc
$645.7M
MLAB
Mesa Laboratories Inc
$433.5M
CYRX
Cryoport Inc
P/E 7.1
$480.7M
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.14 | $0.09 | $-0.05 |
| Sep 2025 | $0.19 | $0.21 | +$0.02 |
| Jun 2025 | $0.14 | $0.19 | +$0.05 |
| Mar 2025 | $0.07 | $0.05 | $-0.02 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $147.4M | $143.4M | $143.9M | $159.0M | $148.6M |
| Net Income | — | -$11.0M | -$40.5M | -$52.8M | $50.8M | -$15.4M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -6.5% | -6.5% | -6.5% | -6.5% | -6.5% | -3.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -36.7% | -18.4% | -18.4% | -18.4% | -18.4% | -9.4% |
| Gross Margin | 47.1% | 44.9% | 44.9% | 44.9% | 44.9% | 45.5% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 |
| Current Ratio | 2.76 | 2.76 | 2.76 | 2.76 | 2.76 | 2.98 |
Key Ratios
ROA (TTM)
-2.7%
P/S (TTM)
2.58
P/B
0.8
EPS (TTM)
$-1.22
CF/Share
$1.10
Rev Growth 3Y
+2.3%
52W High
$55.64
52W Low
$23.91
$23.91
52-Week Range
$55.64
Financial Health
Free Cash Flow
$14.7M
Net Debt
-$282.2M
Cash
$336.6M
Total Debt
$54.5M
As of Dec 31, 2025
How does AZTA compare to Life Sciences Tools & Services peers?
Peer group: Small-cap Life Sciences Tools & Services ($300M+) · 25 companies
AZTA valuation vs Life Sciences Tools & Services peers
P/E ratio
—
▼
0%
below
peers
(32.5)
vs Peers
vs Industry
Fair value
P/S ratio
2.6
▼
33%
below
peers
(3.8)
vs Peers
vs Industry
Pricier
P/B ratio
0.8
▼
80%
below
peers
(3.7)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.5%)
vs Peers
vs Industry
Low yield
AZTA profitability vs Life Sciences Tools & Services peers
ROE
-3.3%
▲
0%
above
peers
(-3.3%)
vs Peers
vs Industry
In line
Net margin
-9.4%
▲
0%
above
peers
(-9.4%)
vs Peers
vs Industry
In line
Gross margin
45.5%
▼
5%
below
peers
(48.0%)
vs Peers
vs Industry
Weak
ROA
-2.7%
▼
5%
below
peers
(-2.6%)
vs Peers
vs Industry
In line
AZTA financial health vs Life Sciences Tools & Services peers
D/E ratio
0.1
▼
100%
below
peers
(36.5)
vs Peers
vs Industry
Low debt
Current ratio
3.0
▼
12%
below
peers
(3.4)
vs Peers
vs Industry
In line
Beta
1.4
▼
5%
below
peers
(1.4)
vs Peers
vs Industry
Less volatile
AZTA fundamentals radar
AZTA
Peer median
Industry
AZTA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
AZTA vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
NOVA TINA SUSAN
Director · Feb 06
5663 shs
DOSHI DIPAL
Director · Feb 05
5663 shs
MCLAUGHLIN ERICA
Director · Feb 05
5663 shs
CASAL FRANK
Director · Feb 05
7243 shs
Last 90 days
Top Holders
Top 5: 43.2%Blackrock Inc.
14.72%
$134.9M
Politan Capital Management …
10.02%
$91.9M
Vanguard Group Inc
9.85%
$90.3M
Dimensional Fund Advisors LP
4.56%
$41.8M
Millennium Management Llc
4.05%
$37.1M
As of Dec 31, 2025
Dividends
$0.40
/ year
Dec 02, 2021
$0.1000
Sep 02, 2021
$0.1000
Jun 03, 2021
$0.1000
Mar 04, 2021
$0.1000
Dec 03, 2020
$0.1000
Sep 03, 2020
$0.1000
Jun 04, 2020
$0.1000
Mar 05, 2020
$0.1000
Latest News
No related news yet